Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Quon

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Frontiers in Oncology|June 20, 2019
FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot StudySusan M Hiniker, Quaovi Sodji, Andrew Quon, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2012
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapyJonathan A Abelson, James D Murphy, Nicholas Trakul, et al.
Archives of Dermatology|May 17, 2006
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomographyEunice Y Tsai, Alan Taur, Leandro Espinosa, et al.
Clinical Lung Cancer|March 5, 2022
Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CTQuaovi H Sodji, Jeremy P Harris, Andrew Quon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
European Radiology|April 7, 2016
Speeding up PET/MR for cancer staging of children and young adultsMaryam Aghighi, Laura Jean Pisani, Ziyan Sun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Molecular Imaging and Biology|March 17, 2004
Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's diseaseJean-Emmanuel Filmont, Cecelia S Yap, Fred Ko, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Frontiers in Oncology|June 20, 2019
FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot StudySusan M Hiniker, Quaovi Sodji, Andrew Quon, et al.
Cancer Research|June 20, 2012
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancerViswam S Nair, Olivier Gevaert, Guido Davidzon, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2012
Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapyJonathan A Abelson, James D Murphy, Nicholas Trakul, et al.
Archives of Dermatology|May 17, 2006
Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomographyEunice Y Tsai, Alan Taur, Leandro Espinosa, et al.
Clinical Lung Cancer|March 5, 2022
Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CTQuaovi H Sodji, Jeremy P Harris, Andrew Quon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2019
Can the Injected Dose Be Reduced in <sup>68</sup>Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?Isabel Rauscher, Wolfgang P Fendler, Thomas A Hope, et al.
European Radiology|April 7, 2016
Speeding up PET/MR for cancer staging of children and young adultsMaryam Aghighi, Laura Jean Pisani, Ziyan Sun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaMatthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Molecular Imaging and Biology|March 17, 2004
Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's diseaseJean-Emmanuel Filmont, Cecelia S Yap, Fred Ko, et al.
Pageof 10